STAAR Surgical (STAA) Misses Q4 EPS by 52c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts STAA Hot Sheet
Price: $25.17 --0%
Revenue Growth %: -16.9%
Financial Fact:
Research and development: 4.45M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: -16.9%
Financial Fact:
Research and development: 4.45M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of ($0.37), $0.52 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $239.4 million versus the consensus estimate of $75.37 million.
For earnings history and earnings-related data on STAAR Surgical (STAA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Avnet (AVT) Tops Q1 EPS by 97c ; Offers Guidance
- XPEL, Inc. (XPEL) Tops Q3 EPS by 4c, Misses on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
